133 related articles for article (PubMed ID: 35471653)
61. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Sakin A; Sahin S; Karyagar SS; Karyagar S; Atci M; Akboru MH; Cihan S
J Gastrointest Cancer; 2022 Jun; 53(2):341-347. PubMed ID: 33651265
[TBL] [Abstract][Full Text] [Related]
62. Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis.
Tochigi T; Kamran SC; Parakh A; Noda Y; Ganeshan B; Blaszkowsky LS; Ryan DP; Allen JN; Berger DL; Wo JY; Hong TS; Kambadakone A
Eur Radiol; 2022 Apr; 32(4):2426-2436. PubMed ID: 34643781
[TBL] [Abstract][Full Text] [Related]
63. Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal Cancer.
Koo PJ; Kim SJ; Chang S; Kwak JJ
Clin Colorectal Cancer; 2016 Dec; 15(4):e213-e219. PubMed ID: 27316919
[TBL] [Abstract][Full Text] [Related]
64. Optimal Interval for
Kawai K; Nozawa H; Hata K; Tanaka T; Nishikawa T; Oba K; Watanabe T
Clin Colorectal Cancer; 2018 Jun; 17(2):e163-e170. PubMed ID: 29208445
[TBL] [Abstract][Full Text] [Related]
65. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
[TBL] [Abstract][Full Text] [Related]
66. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Lee SJ; Kim JG; Lee SW; Chae YS; Kang BW; Lee YJ; Park JS; Choi GS
Cancer Chemother Pharmacol; 2013 May; 71(5):1201-7. PubMed ID: 23420438
[TBL] [Abstract][Full Text] [Related]
67. Association of visual and quantitative heterogeneity of 18F-FDG PET images with treatment response in locally advanced rectal cancer: A feasibility study.
Martin-Gonzalez P; de Mariscal EG; Martino ME; Gordaliza PM; Peligros I; Carreras JL; Calvo FA; Pascau J; Desco M; Muñoz-Barrutia A
PLoS One; 2020; 15(11):e0242597. PubMed ID: 33253194
[TBL] [Abstract][Full Text] [Related]
68. Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes.
Choi H; Yoon HJ; Kim TS; Oh JH; Kim DY; Kim SK
Nucl Med Commun; 2013 Dec; 34(12):1166-73. PubMed ID: 24128896
[TBL] [Abstract][Full Text] [Related]
69. MRI-based radiomic score increased mrTRG accuracy in predicting rectal cancer response to neoadjuvant therapy.
Miranda J; Horvat N; Assuncao AN; de M Machado FA; Chakraborty J; Pandini RV; Saraiva S; Nahas CSR; Nahas SC; Nomura CH
Abdom Radiol (NY); 2023 Jun; 48(6):1911-1920. PubMed ID: 37004557
[TBL] [Abstract][Full Text] [Related]
70. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
[TBL] [Abstract][Full Text] [Related]
71. 18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis.
Li C; Lan X; Yuan H; Feng H; Xia X; Zhang Y
Ann Nucl Med; 2014 Jun; 28(5):436-46. PubMed ID: 24623152
[TBL] [Abstract][Full Text] [Related]
72. Pre-treatment ADC image-based random forest classifier for identifying resistant rectal adenocarcinoma to neoadjuvant chemoradiotherapy.
Yang C; Jiang ZK; Liu LH; Zeng MS
Int J Colorectal Dis; 2020 Jan; 35(1):101-107. PubMed ID: 31786652
[TBL] [Abstract][Full Text] [Related]
73. Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis.
Maffione AM; Marzola MC; Capirci C; Colletti PM; Rubello D
AJR Am J Roentgenol; 2015 Jun; 204(6):1261-8. PubMed ID: 26001237
[TBL] [Abstract][Full Text] [Related]
74. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
75. MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Fang Z; Pu H; Chen XL; Yuan Y; Zhang F; Li H
Abdom Radiol (NY); 2023 Jul; 48(7):2270-2283. PubMed ID: 37085730
[TBL] [Abstract][Full Text] [Related]
76. Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer.
Vollenbrock SE; Voncken FEM; Lambregts DMJ; Maas M; Donswijk ML; Vegt E; Ter Beek LC; van Dieren JM; van Sandick JW; Aleman BMP; Beets-Tan RGH; Bartels-Rutten A
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):176-185. PubMed ID: 32572560
[TBL] [Abstract][Full Text] [Related]
77. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
78.
Avallone A; Aloj L; Pecori B; Caracò C; De Stefano A; Tatangelo F; Silvestro L; Granata V; Bianco F; Romano C; Di Gennaro F; Budillon A; Petrillo A; Muto P; Botti G; Delrio P; Lastoria S
J Nucl Med; 2019 Nov; 60(11):1560-1568. PubMed ID: 30877175
[TBL] [Abstract][Full Text] [Related]
79. Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer.
Babatürk A; Erden A; Geçim İE
Diagn Interv Radiol; 2022 Sep; 28(5):403-409. PubMed ID: 35997474
[TBL] [Abstract][Full Text] [Related]
80. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
